Healionics
Healionics is a clinical-stage company addressing the critical need for safer, more reliable means of bloodstream access to perform dialysis in patients with kidney failure. Our STARgraft vascular graft (synthetic blood vessel) is designed to resist the problems of infection and occlusion suffered by current devices. We also have an exciting product pipeline based on our platform STAR biomaterial, which has a unique ability to prevent two serious problems that affect all implantable devices: scarring and infection. The company is currently conducting human studies of STARgraft and has 33 patents issued or pending.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Nationally (across the country)
About Us
Our Seattle location has facilitated strong connections and collaboration with several organizations that have pioneered the life-saving devices and clinical innovations needed to treat kidney failure with dialysis. These include University of Washington (where the first device for long-term blood access and early dialysis machines were invented), Northwest Kidney Centers (the world’s first outpatient dialysis center), Kidney Research Institute, and Center for Dialysis Innovation.
Healionics was recently honored to receive the Angel Capital Association’s 2022 Villalobos Award which recognizes “the most ingenious and innovative” life science company recently ?nanced by ACA members.
Facilities
Healionics corporate headquarters in Seattle, Washington is an integrated facility that includes a fully equipped laboratory as well as cleanroom manufacturing space. This facility enables our scientists and engineers to perform research, development and production functions to best meet the STAR biomaterial needs of our research partners and product customers.
Quality
Healionics has an established Quality System certified to ISO 13485
ISO 13485:2016 / EN ISO 13485:2016
This internationally recognized quality standard ensures that the necessary comprehensive quality management systems and procedures are in place to safely design, develop, manufacture and distribute medical devices.